Xarelto 2.5 mg film-coated tablets
rivaroxaban
You have been prescribed Xarelto because
Xarelto reduces the risk of having another heart attack in adults, or reduces the risk of death due to heart disease or blood vessel disease.
You will be prescribed Xarelto together with another medicine. Your doctor will also tell you to take:
or
You will be prescribed Xarelto together with another medicine. Your doctor will also tell you to take aspirin.
In some cases, if you are given Xarelto after a procedure to open a narrowed or blocked artery in your leg to restore blood flow, your doctor may also prescribe clopidogrel for you to take in addition to aspirin for a short period of time.
Xarelto contains the active substance rivaroxaban, which belongs to a group of medicines called antithrombotic agents. It works by blocking a factor in blood clotting (factor Xa) and thus reducing the tendency of blood to form clots.
Do not take Xarelto
Do not take Xarelto and inform your doctorif any of these circumstances apply to you.
Consult your doctor or pharmacist before starting Xarelto.
Xarelto should not be used in combination with other medicines that reduce blood clotting, other than aspirin or clopidogrel/ticlopidine, such as prasugrel or ticagrelor.
Tell your doctor if you have any of these conditionsbefore taking Xarelto. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
Xarelto 2.5 mg tablets are not recommended for children and adolescents under 18 years of age.There is not enough information on its use in children and adolescents.
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines, including those obtained without a prescription.
If any of these circumstances apply to you, tell your doctorbefore taking Xarelto, as the effect of Xarelto may be increased. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
If your doctor considers that you have a higher risk of developing a stomach or intestinal ulcer, he may also recommend a preventive treatment.
If any of these circumstances apply to you, tell your doctorbefore taking Xarelto, as the effect of Xarelto may be reduced. Your doctor will decide if you should be treated with Xarelto and if you should be kept under closer observation.
Do not take Xarelto if you are pregnant or breastfeeding. If there is a possibility that you may become pregnant, use a reliable contraceptive while taking Xarelto. If you become pregnant while taking Xarelto, tell your doctor immediately, who will decide how you should be treated.
Xarelto may cause dizziness (common side effect) or fainting (uncommon side effect) (see section 4, "Possible side effects"). Do not drive, ride a bicycle or use tools or machines if you are affected by these symptoms.
If your doctor has told you that you have an intolerance to some sugars, consult him before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
Follow exactly the instructions of administration of this medicine indicated by your doctor. If you are in doubt, consult your doctor or pharmacist again.
The recommended dose is one 2.5 mg tablet twice a day. Take Xarelto at the same time every day (e.g. one tablet in the morning and one in the evening). This medicine can be taken with or without food.
If you have difficulty swallowing the tablet whole, consult your doctor about other ways to take Xarelto. The tablet can be crushed and mixed with water or apple sauce, immediately before taking it.
If necessary, your doctor may also administer the crushed Xarelto tablet through a gastric tube.
You will be prescribed Xarelto together with another medicine.
Your doctor will also tell you to take aspirin. If you receive Xarelto after an acute coronary syndrome, your doctor may also tell you to take clopidogrel or ticlopidine.
If you are given Xarelto after a procedure to open a narrowed or blocked artery in your leg to restore blood flow, your doctor may also prescribe clopidogrel for you to take in addition to aspirin for a short period of time.
Your doctor will tell you the dose to take (usually between 75 and 100 mg of aspirin per day, or a dose of 75 to 100 mg of aspirin plus a daily dose of 75 mg of clopidogrel or a standard daily dose of ticlopidine).
Treatment with Xarelto after an acute coronary syndrome should be started as soon as possible, once the acute coronary syndrome has been stabilized, i.e. from 24 hours after hospital admission and at the time when parenteral anticoagulant treatment (by injection) would be discontinued.
Your doctor will tell you when to start treatment with Xarelto if you have been diagnosed with coronary artery disease or peripheral artery disease.
The doctor will decide how long you should continue taking the treatment.
Call your doctor immediately if you have taken too many Xarelto tablets. Taking too much Xarelto increases the risk of bleeding.
Do not take more than one tablet in one day to make up for a forgotten dose. If you forget to take a dose, take the next tablet at the usual time.
Take Xarelto regularly for the time indicated by your doctor.
Do not stop taking Xarelto without talking to your doctor first. If you stop taking this medicine, you may increase your risk of having another heart attack, stroke or dying from a heart or blood vessel disease.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Like other similar medicines to reduce blood clotting, Xarelto can cause bleeding that can put your life at risk. Excessive bleeding can cause a sudden drop in blood pressure (shock). In some cases, the bleeding may not be visible.
Your doctor will decide whether to keep you under closer observation or change your treatment.
The frequency of these side effects is very rare (up to 1 in 10,000 people).
The frequencies of severe allergic reactions are very rare (anaphylactic reactions, including anaphylactic shock; may affect up to 1 in 10,000 people) and uncommon (angioedema and allergic edema; may affect up to 1 in 100 people).
Frequent(may affect up to 1 in 10 people)
Infrequent(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very Rare(may affect up to 1 in 10,000 people)
Frequency Not Known(frequency cannot be estimated from available data)
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this prospectus. You can also report it directly through the national reporting system included in Appendix V. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date shown on the packaging and on each blister or bottle after "CAD" or "EXP". The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Crushed tablets
Crushed tablets are stable in water or apple sauce for up to 4 hours.
Medicines should not be thrown away through wastewater or household waste. Ask your pharmacist how to dispose of packaging and medicines that are no longer needed. This will help protect the environment.
Xarelto Composition
Tablet core: microcrystalline cellulose, sodium croscarmellose, lactose monohydrate, hypromellose (2910), sodium lauryl sulfate, magnesium stearate. See section 2 "Xarelto contains lactose and sodium".
Tablet film coating: macrogol (3350), hypromellose (2910), titanium dioxide (E 171), yellow iron oxide (E 172).
Xarelto 2.5 mg film-coated tablets are pale yellow, round, biconvex, and have the Bayer cross engraved on one side, and "2.5" and a triangle on the other.
They are packaged
Not all pack sizes may be marketed.
Bayer AG
51368 Leverkusen Germany
The manufacturer can be identified by the batch number printed on the side flap of the box and on each blister or bottle:
Kaiser-Wilhelm-Allee 51368 Leverkusen Germany
Via delle Groane, 126 20024 Garbagnate Milanese Italy
Ortsteil Greppin, Salegaster Chaussee 1 06803 Bitterfeld-Wolfen
Germany
You can request more information about this medication from the local representative of the marketing authorization holder:
Belgium / Belgium / Belgium Bayer SA-NV Tel: +32-(0)2-535 63 11 | Lithuania UAB Bayer Tel: +370-5-233 68 68 |
Bulgaria Bayer EOOD Tel: +359-(0)2-424 72 80 | Luxembourg / Luxembourg Bayer SA-NV Tel: +32-(0)2-535 63 11 |
Czech Republic Bayer s.r.o. Tel: +420-266 101 111 | Hungary Bayer Hungária KFT Tel: +36-1-487 4100 |
Denmark Bayer A/S Tel: +45-45 235 000 | Malta Alfred Gera and Sons Ltd. Tel: +356-21 44 62 05 |
Germany Bayer Vital GmbH Tel: +49-(0)214-30 513 48 | Netherlands Bayer B.V. Tel: +31–(0)297-28 06 66 |
Estonia Bayer OÜ Tel: +372-655 85 65 | Norway Bayer AS Tel: +47-23 13 05 00 |
Greece Bayer Ελλάς ΑΒΕΕ Tel: +30-210-618 75 00 | Austria Bayer Austria Ges. m. b. H. Tel: +43-(0)1-711 460 |
Spain Bayer Hispania S.L. Tel: +34-93-495 65 00 | Poland Bayer Sp. z o.o. Tel: +48-22-572 35 00 |
France Bayer HealthCare Tel (Green Number): +33-(0)800 87 54 54 | Portugal Bayer Portugal, Lda. Tel: +351-21-416 42 00 |
Croatia Bayer d.o.o. Tel: + 385-(0)1-6599 900 | Romania SC Bayer SRL Tel: +40-(0)21-528 59 00 |
Ireland Bayer Limited Tel: +353 1 216 3300 | Slovenia Bayer d. o. o. Tel: +386-(0)1-58 14 400 |
Iceland Icepharma hf. Tel: +354-540 80 00 | Slovak Republic Bayer, spol. s r.o. Tel: +421-(0)2-59 21 31 11 |
Italy Bayer S.p.A. Tel: +39-02-3978 1 | Finland Bayer Oy Tel: +358-(0)20-78521 |
Cyprus NOVAGEM Limited Tel: +357-22-48 38 58 | Sweden Bayer AB Tel: +46-(0)8-580 223 00 |
Latvia SIA Bayer Tel: +371-67 84 55 63 | United Kingdom Bayer plc Tel: +44-(0)118 206 3000 |
Detailed information on this medication is available on the European Medicines Agency website http://www.ema.europa.eu.